Page last updated: 2024-09-04

atrasentan and Leukemia P388

atrasentan has been researched along with Leukemia P388 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haefeli, WE; Weiss, J	1

Other Studies

1 other study(ies) available for atrasentan and Leukemia P388

Article	Year
Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Atrasentan; Cell Line; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Drug Resistance, Multiple; Endothelin A Receptor Antagonists; Enzyme Induction; Humans; Inhibitory Concentration 50; Leukemia P388; Mice; Neoplasm Proteins; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2011

Article

Year

Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.

Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Atrasentan; Cell Line; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Drug Resistance, Multiple; Endothelin A Receptor Antagonists; Enzyme Induction; Humans; Inhibitory Concentration 50; Leukemia P388; Mice; Neoplasm Proteins; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2011